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Mutations in the genes encoding laminin 5 (LAMA3, 
LAMB3, and LAMC2) have been delineated in the 
autosomal recessive blistering skin disorder, junc-
tional epidermolysis bullosa, particularly in the lethal 
(Herlitz) variant. In this study, we searched for mu-
tations in these genes in two patients with nonlethal 
forrns of junctional epidermolysis bullosa using poly-
merase chain reaction amplification of genomic 
DNA, followed by heteroduplex analysis and direct 
automated nucleotide sequencing. Both patients 
I n th e lethal (H e rlitz) fo rms o f junction a l epide rm o lysis bull osa OED), severa l difFe re nt premature termination cod o n mutatio n s have b een fo und on b oth alleles of e ithe r the LAMA3, LAMB3 , o r LAMC2 gen es that encode lami-nin 5 (Aberdam el ai, 1994; IGvirikko el a/, 1995; M cGrath 
et ai, 1995b ; Pulkkinen et a/. 1994 b) . In the n o nlethal forms ofJEB. 
fewe r mutatio n s ba ve been d escribed . T h ese con sist of pre mature 
termination cod ons in both all e les of the BPAG2 gen e in a patient 
with the gen e r alized atrophic b e nig n epidermolysis bu llosa variant 
of nonlethal J ED (McGrath eI a/. 1995a) , a homozygo u s in-frame 
exon skipping muta t ion in the LAMC2 gen e in a subty p e of 
nonlethal J EB (Pulkkine n et a/. 1994a) and compound h eterozygos-
ity for a nonsen se and missense mutatio n in the LAMB3 gen e in 
another p e dig ree with gen e ralized atr o phic b e nig n e pide rmolys is 
buUosa (McGrath el n/, 1995c). 
In this study, we report two cases of nonle thal J EB with a 
com bination of a nonse nse and a missense muta tion in the LAMD3 
gene, su gges ting that this partic ular combin ation of mutations ma y 
be important in the path ogen es is of t his form of inhe rite d bli stering 
skin disease. 
MATERIALS AND METHODS 
Clinicopathological Features Paticllt 1 is a l-yea r-o ld female in f:1 nt of 
un.re lated, c linj ca ll Y ll o rnlai parcnts o f N o rth AI11cri can Caucas ian an cestry. 
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were found to be compound heterozygotes for the 
same nonsense mutation on one LAMB3 allele, and 
different missense mutations on the other LAMB3 
allele . The combination of a nonsense and a missense 
n"lutation in the LAMB3 gene appears to be important 
in determining the milder clinical phenotype in some 
cases of the nonlethal forms of junctional epidermol-
ysis bullosa involving abnormalities in laminin 5. Key 
lVol'ds: lalll;IIill 5lallcllo/'illg jilalllellts. ] ],,,,est Demratol 
106:775-777, 1996 
T here was no hi story of a blistering di so rder in the f.1 mil y. A t birth . a few 
sca ttered b listers were present o n th e trunk and linlbs. Over subsequent 
weeks and Ill o nths. tnild . traul11a-associa ted bli stering and crusting acetin-cd 
on the back . gro in area . e lbows. hands. and feet. There has been no 
significant muco us fll Ct11bran c involvcn1cnt to date. however. Electron 
microscopic examination of skin showed a lamina lucida plane of cleavage 
consistent with a diagnosis of J E13. 
Pati ent 2 is a 75- yea r-o ld Northern Europea l1 C~lucasi.,n W01113n with 
generali zed trauma-induced blistering since birth , predominantly affecting 
the sacra l area. Other clinical feattlres include scarrin g alopecia. esophageal 
stric ture fornlatioll. and dystrophi c teeth and nail s. There is nO relevant 
f.1 l11ily history. and the unrelated parents. now deceased. were clinica ll y 
Ho rmal. InlnlulloAuo rcscencc 111i croscopy of the cutaneous b aSClllcnt ItlCrll-
branc zOll e revea led reduced sta ining with an antibody (GB3) to lamini n 5 
(Kennedy ('( nl. 1985; Schofic ld e( nl. 1990). Electron l11icroscop y showed 
blister fOnll<ltion w ithin the 13111i11a lucida. but no gross changcs in hCJ1lides-
1110somc and anchorin g filament morphology (Tidman and Eady. 1986). 
Overall , tI,ese fi ndings are consistent witll a 1I0nlethal [oml ofJE13 . 
Mutation Analysis DNA w as isolated from peripheral blood lympho-
cytes from patient I . the parents of patient 1. and J atient 2 by standard 
mcthods (Sambrook e ( nl. 1989) and used as a templatc [or ampli flcation of 
individual exons of the LAMA3, LAMB3. and LAMe2 gencs . O li gon ucle-
otide pritlle rs were syn th csized o n th e basis of in tronic !'cqu cnces. as 
described previo usly (Pulk.lcinell e( al. 1995). Specifi ca ll y. to amplify cxOllS 
7. 10. and 14 of LAMB] (sec Reslllts) the fo l.l owing primers were used: 
c"on 7. sense primer: 5' AGGTTTCTTCTGAACTCGGG 3'; 
e"on 7. antisense primer: 5' GCAGGGCAAGTATCAAATCC 3' . 
ex O il 10, scnse primer: 5 ' GAGTTGTTACAGATGCCAGT 3 ' ; 
exon 10. antisense primer: 5' TCTCCCCACAAATCCTGACTC 3' . 
exon 14. sense primer: 5 ' GCTGCGACTTCTGITATTCT 3' ; 
ex O il 14. antisense primer: 5 ' AAATGTAAGGAAGGACCAGC 3 ' . 
The polym erase chaill reaction (PCR) amplification conditions were thc 
same as described previously. Aliquots of 5 ,....1 of the PCR products were 
analyzed by 2tX) tlgarosc gel electrophoresis. To detect seq uen ce vanaJ~ ts . 
the PCR produ cts were either subjected directly to auto lll ated nucleotide 
sequencing (A13 I) . or 3- 8 ,....1 of the sample was screened by heteroduplcx 
analysis using confornlation-sc nsitivc ge l electrophoresis (Ga ngu ly cl nl. 
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Figure 1. Idcntification of a nonsense mutation (R635X) ill Ol1e 
LAMB3 allele in both affccted individuals. A) Automated nucleot.ide 
sequencing of the PCR products encompassing exon 14 in both patient 1 
and patient 2 reveals a heterozygous C-to-T transition at position 1903 that 
con verts an arginine residue (CGA) to a premature termination codon 
(IGA) . This mutation is designated R635X. B) T he R635X mutation 
creates a new restriction site for the endonuclease BgII!. T he control PCR 
product shows a single , undigested band, 578 bp in size. In contrast, the 
samples from both patient 1 and patient 2 have additiona l b'lIlds, 428 ,,,,d 
J 50 bp in size. Digestion of the ampli fied DNA of the filt her of patient I also 
shows the additional bands, indicating that he is a heterozygo lls carrier of 
the munition R635X. The PCR product of the mother of patient 1 is not 
digested by BglII , as seen in the control sample. 
1993), fo llowed by direct auto mated sequencing of PCR products display-
ing bands of altered mobility. 
Verification of the Mutations The mutations detected in the PCR. 
products (sec Results) were verified in genomic DNA . To verify the 
mutations in eXOn 7 and exon 10 in LANlB3, oligonucleotide probes 
covering the site of the mutatiO/lS were designed for all ele-specifi c o ligo-
(A) 
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nucleotide (ASO) hybridization of the PCR. products spanning the muea, 
tiOllS . A st:lndard ASO pro tocol was used (Dietz et ai, 1992). The probc\ 
were as follows: 
exon 7; wild type, S' AAAAATTCAAGGTC AGTGTGG 3'; 
exon 7; mutated allele , S' AAAAAATTCAAAGTCAGTGTGG 3' . 
exon 10; wild type , 5' CGGGACCAC~CCGAAGGCAA 3'; 
cxon 10; J1lutated allele, 5' CGGGACCACCCCGAAGGCA 3'. 
Fifty etbn ic"lIy marched , unrelated healthy control subjects were als~ 
assessed for the prese nce or absence of this mutation. 
T he exon 14 mutation in LAMB3 created a new restriction site for dl~ 
endo nuclease BglI!. T he PCR products spanning tllis ex on were digesteq 
with this enzyme according to the maJluF.,ccurcr 's iusrrLl cnollS (N e" . 
England UioJabs, Inc., Beverly, MA) . 
RESULTS 
Identification of the Same Nonsense Mutation in on~ 
LAMB3 Allele in Both Affected Individuals Direct nucleo, 
tide sequencing of the PCR products spanning exon J 4 (Fig lA) ~ 
both patient 1 and patient 2 revealed a C-to-T transition a\ 
nucleotide position 1903 (GenBank accession number L25541) that 
converts all arginine codon (CGA) to a stop codon (IGA) . T~ 
mutation , designated R635X, creates a new restriction sice for thl{ 
endonuclease BglIl. Digestion of the l)C R products wlth tl~ 
enzyme (Fig lB) showed an undigested band of578 bp in amplifieq 
control DNA. T he PCR products of both patients displayeq 
digestion products 578, 428, and 150 bp in size, however, indicat, 
ing heterozygosity for the presence of this mutation . [n addition, 
similar bands were seen in the digested amplified DNA sample frOI1\ 
the filther of patient 1, indi ca ting that he is a heterozygous carrie~ 
of this mutation. The m aternal sample was not cleaved by Bgl11 , 
similar to the control sample enzyme diges tion . 
Identification of Diifel'ent Missense Mutations ill the Othe~ 
LAMB3 Allele in Both Affected Individuals [11 patient 11 
beteroduplex analysis of the PCR product spanning exon 7 of 
LAMB3 (Fig 2A) revealed heteroduplex formation in addition to ~ 
bomoduplex band . This bandshift was also present in the macerna( 
sample , but not in the PCR product from the father, a comrol 
individual, 01· patient 2. Direct nucleotide sequencing (Fig 2B} 
revealed a G-to-A transition at nucleotide position 628 that con, 
verts a glutam.ic acid residue (GAG) to a lysine residue (AAG). Thi 
mutation, designated E210K, was verified by ASO (Fig 2C). 
Assessment of 50 DNA samples from unrel ated control individuals 
by ASO fililed to demonstrate the presence of this missense 
mutation . 
in patient 2, direct nucleotide sequencing of th e PCR product 
spanniJlg exon 10 of LAMB3 (Fig 3B) revea led an A- to-C crans-
version at nucleotide posicion 1048 that converts a threonine 
residu e (ACe) to a proline residue eCCC). T his mutation, desig-
nated T350P, was verified by ASO. Assessment 0[50 DNA sample 
(8) Figure 2. Identification of the missense mutation E210K in one LAMB3 allele in 
patient 1. A) Hcteroduplex analysis of the PC R 
products spanning exon 7 shows hctcroduplex 
formation in addition to a homoduplex band in 
the amplified DNA from patient 1 and the 
mother of patient 1. In con trast, 0 111)' the horno-
duplex band is detected in the samples from the 
father of patient 1 and the control individual. B) 
Nucleotide sequencing of the PCR. product of 
patient 1 revea ls a heterozygous G-to-A transi-
tion at position 628 that converts a split glutamic 
acid codon (GAG) to a lysine residue (~AG). 
The mutadon is designated £21 OK. C) Verifica-
tion of the missense mutation by ASO shows 
signals for the wild type (111/) and the mutant 
(1111<1) sequences in the PCR. product of patient 1 
and the mother of patient 1, but only the wild 
type signal is present in the father of patient 1 
and the control sample. 
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Figure 3. Identification of the missense mutation T350P in one 
lAMBJ allele ill patient 2. A) Automated nucleotide sequencing of the 
PCR product encompassing eXOIl lOin patient 2 reveal s a heterozygous 
A-co-C transversion at nucleotide position 1048 that converts a threonine 
residue (ACe) to a proline residue (eCC). The mutation is designated 
T350P. B) Verification of the missense mutation by ASO shows signals for 
the wild type and mutant sequences in the amplified DNA of patient 2, but 
only the wild type signal in the control sample. 
from unrelated control individuals by ASO failed to demonstrate 
the presence of this missense mutation . 
DISCUSSION 
Both nonlethal JEB patients in this study are compound heterozy-
gores for a nonsense mutation on one LAMB3 allele and a missense 
mutation on the other LAMB3 allele. The nonsense mutation 
consists of a premature termination codon in exon 1.4, designated 
R635X. This mutation is expected to result in an unstable mRNA 
transcript and, as a consequence, an absence of protein from this 
allele (Urlaub ct ai, 1989; Cheng cl ai, 1990). Tlus hypothesis is 
supported by a previous demonstration of a complete lack of 
LAMB3 mR.NA in a patient with JEB homozygous for the R635X 
mut.1.tion (Pulkkinen ct ai, 1994b). Interestingly, this nonsense muta-
tion has also been observed in several other unrelated patients with 
lethal (Herlitz) and nonlethal fonns of JEB &om diverse etlmic 
backgrounds (Kivirikko et ai, 1996) and would therefore appear to 
constitute a mutationa'! hotspot in the LA.NfB3 gene. 
Both the nonsense mutation and the two missense mutations 
delineated i.n tlus study could not be demonstrated in 100 unrelated 
chromosomes within e tluucaUy matched control populations, argu-
ing against tllese amino acid substitutions representing nonpatho-
genetic polymorphisms. The mutation E210K has been previously 
reported in a different family with nonlethal JEB (McGrath et ai, 
1995c), but has not been detected in mutational screelung of more 
than 30 other patients with different forms of JEB (McGrath et ai , 
1995c; McGrath JA et ai, unpublished data) , arguing against E21 OK 
representing a common pathogenetic mutation in nonletllal JEB. 
The conversion of glutamic acid to lysine causes a marked change 
in polarity and occurs in a region of the laminin 5 molecule, domain 
VI, th at is potentially important in protein-protein interactions 
involving laminin 5 witllin the cutaneous basement membrane 
zone. The mutation T350P occurs at a tllreonine residue within 
domain rIl I V of the short arm of the {33 chain. It is possible that the 
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introduction of a proline residue into tll;S part of the molecule 
results in a conformational change of tile (33 chain short arm , 
disrupting the normal function of the protein. . 
Although mutations in other gen es, including LAMC2 and 
BPAG2, have been reported as the molecular basis for som e cases 
of nonlethal JEB, this study suggests that mutations in the LAMB3 
gene may also be relevant to tlle pathogenesis of this heterogeneous 
group of inherited blistering skin diseases . Furthermore, the com-
bination of a nonsense and a missense mutation in tlus gene appears 
to influence the JEB phenotype by resulting in a nonlethal foml of 
the disease , whereas nonsense mutations on both LAMB3 aUeles 
unequivocaUy result in the le thal (Herlitz) variant of JEB . 
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